Staging of Human Papilloma Virus Related Cancers of the Oropharynx

Overview

Journal J Surg Oncol

Specialties General Surgery
Oncology

Date 2021 Oct 8

PMID 34622962

Authors

Cristina Valero

Jatin P Shah

Affiliations

Soon will be listed here.

Abstract

For the past two decades an increasing number of oropharyngeal cancers have been found to be associated with the human papilloma virus (HPV). These tumors are a biologically distinct entity with better prognosis and excellent response to therapy. Therefore, a separate staging system has been introduced for HPV-related oropharyngeal tumors in the latest edition of the American Joint Committee on Cancer (AJCC eighth Ed).

References

Maxwell J, Ferris R, Gooding W, Cunningham D, Mehta V, Kim S . Extracapsular spread in head and neck carcinoma: impact of site and human papillomavirus status. Cancer. 2013; 119(18):3302-8. DOI: 10.1002/cncr.28169. View

Rischin D, Young R, Fisher R, Fox S, Le Q, Peters L . Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol. 2010; 28(27):4142-8. PMC: 2953971. DOI: 10.1200/JCO.2010.29.2904. View

DSouza G, Kreimer A, Viscidi R, Pawlita M, Fakhry C, Koch W . Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007; 356(19):1944-56. DOI: 10.1056/NEJMoa065497. View

Straetmans J, Olthof N, Mooren J, de Jong J, Speel E, Kremer B . Human papillomavirus reduces the prognostic value of nodal involvement in tonsillar squamous cell carcinomas. Laryngoscope. 2009; 119(10):1951-7. DOI: 10.1002/lary.20593. View

Chaturvedi A, Engels E, Anderson W, Gillison M . Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008; 26(4):612-9. DOI: 10.1200/JCO.2007.14.1713. View

De Felice F, Bird T, Michaelidou A, Thavaraj S, Odell E, Sandison A . Radical (chemo)radiotherapy in oropharyngeal squamous cell carcinoma: Comparison of TNM 7th and 8th staging systems. Radiother Oncol. 2020; 145:146-153. DOI: 10.1016/j.radonc.2019.12.021. View

Ang K, Harris J, Wheeler R, Weber R, Rosenthal D, Nguyen-Tan P . Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010; 363(1):24-35. PMC: 2943767. DOI: 10.1056/NEJMoa0912217. View

Tota J, Best A, Zumsteg Z, Gillison M, Rosenberg P, Chaturvedi A . Evolution of the Oropharynx Cancer Epidemic in the United States: Moderation of Increasing Incidence in Younger Individuals and Shift in the Burden to Older Individuals. J Clin Oncol. 2019; 37(18):1538-1546. PMC: 6599405. DOI: 10.1200/JCO.19.00370. View

Fakhry C, Westra W, Li S, Cmelak A, Ridge J, Pinto H . Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008; 100(4):261-9. DOI: 10.1093/jnci/djn011. View

10.

Cramer J, Hicks K, Rademaker A, Patel U, Samant S . Validation of the eighth edition American Joint Committee on Cancer staging system for human papillomavirus-associated oropharyngeal cancer. Head Neck. 2017; 40(3):457-466. DOI: 10.1002/hed.24974. View

11.

Mena M, Frias-Gomez J, Taberna M, Quiros B, Marquez S, Clavero O . Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe. Sci Rep. 2020; 10(1):13219. PMC: 7411067. DOI: 10.1038/s41598-020-70118-7. View

12.

Wittekindt C, Wagner S, Bushnak A, Prigge E, von Knebel Doeberitz M, Wurdemann N . Increasing Incidence rates of Oropharyngeal Squamous Cell Carcinoma in Germany and Significance of Disease Burden Attributed to Human Papillomavirus. Cancer Prev Res (Phila). 2019; 12(6):375-382. DOI: 10.1158/1940-6207.CAPR-19-0098. View

13.

Lydiatt W, Patel S, OSullivan B, Brandwein M, Ridge J, Migliacci J . Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017; 67(2):122-137. DOI: 10.3322/caac.21389. View

14.

Ragin C, Taioli E . Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer. 2007; 121(8):1813-20. DOI: 10.1002/ijc.22851. View

15.

El-Naggar A, Westra W . p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency. Head Neck. 2011; 34(4):459-61. DOI: 10.1002/hed.21974. View

16.

Weinberger P, Yu Z, Haffty B, Kowalski D, Harigopal M, Brandsma J . Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. J Clin Oncol. 2006; 24(5):736-47. DOI: 10.1200/JCO.2004.00.3335. View

17.

OSullivan B, Huang S, Su J, Garden A, Sturgis E, Dahlstrom K . Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol. 2016; 17(4):440-451. DOI: 10.1016/S1470-2045(15)00560-4. View

18.

Andl T, Kahn T, Pfuhl A, Nicola T, Erber R, Conradt C . Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res. 1998; 58(1):5-13. View

19.

Chaturvedi A, Engels E, Pfeiffer R, Hernandez B, Xiao W, Kim E . Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011; 29(32):4294-301. PMC: 3221528. DOI: 10.1200/JCO.2011.36.4596. View

20.

Klozar J, Koslabova E, Kratochvil V, Salakova M, Tachezy R . Nodal status is not a prognostic factor in patients with HPV-positive oral/oropharyngeal tumors. J Surg Oncol. 2012; 107(6):625-33. DOI: 10.1002/jso.23292. View